290 related articles for article (PubMed ID: 11793623)
1. Candida lusitaniae catheter-related sepsis.
Pietrucha-Dilanchian P; Lewis RE; Ahmad H; Lechin AE
Ann Pharmacother; 2001 Dec; 35(12):1570-4. PubMed ID: 11793623
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Candida endophthalmitis accompanying Candida lusitaniae bloodstream infection: A case report.
Yamamoto S; Ikeda M; Fujimoto F; Okamoto K; Wakabayashi Y; Sato T; Tatsuno K; Kaburaki T; Yoshida S; Okugawa S; Koike K; Moriya K
J Infect Chemother; 2018 Feb; 24(2):147-149. PubMed ID: 29102349
[TBL] [Abstract][Full Text] [Related]
4. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
5. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
[TBL] [Abstract][Full Text] [Related]
7. Candida lusitaniae infections in the era of fluconazole availability.
Hawkins JL; Baddour LM
Clin Infect Dis; 2003 Jan; 36(2):e14-8. PubMed ID: 12522762
[TBL] [Abstract][Full Text] [Related]
8. Two cases of fungemia due to Candida lusitaniae and a literature review.
Viudes A; Pemán J; Cantón E; Salavert M; Ubeda P; López-Ribot JL; Gobernado M
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):294-9. PubMed ID: 12072941
[TBL] [Abstract][Full Text] [Related]
9. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
[TBL] [Abstract][Full Text] [Related]
10. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
11. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
12. Candida lusitaniae in Kuwait: Prevalence, antifungal susceptibility and role in neonatal fungemia.
Khan Z; Ahmad S; Al-Sweih N; Khan S; Joseph L
PLoS One; 2019; 14(3):e0213532. PubMed ID: 30845213
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
[TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
Bregenzer T; Evison-Eckstein AC; Frei R; Zimmerli W
Schweiz Med Wochenschr; 1996 Oct; 126(43):1829-33. PubMed ID: 9005522
[TBL] [Abstract][Full Text] [Related]
15. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
Angel-Moreno A; Boronat M; Bolaños M; Carrillo A; González S; Pérez Arellano JL
J Infect; 2005 Oct; 51(3):e85-7. PubMed ID: 16230210
[TBL] [Abstract][Full Text] [Related]
16. Non Candida albicans fungal peritonitis in continuous ambulatory peritoneal dialysis patients.
Kleinpeter MA; Butt AA
Adv Perit Dial; 2001; 17():176-9. PubMed ID: 11510270
[TBL] [Abstract][Full Text] [Related]
17. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
Minari A; Hachem R; Raad I
Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
[TBL] [Abstract][Full Text] [Related]
18. Management of systemic candidal infections in the intensive care unit.
Kam LW; Lin JD
Am J Health Syst Pharm; 2002 Jan; 59(1):33-41. PubMed ID: 11813465
[TBL] [Abstract][Full Text] [Related]
19. [Infections by Candida sp. in intensive care. Survey of French practices].
Gauzit R; Cohen Y; Dupont H; Hennequin C; Montravers P; Timsit JF; Veber B; Chevalier E; Blin P; Palestro B
Presse Med; 2003 Mar; 32(10):440-9. PubMed ID: 12733304
[TBL] [Abstract][Full Text] [Related]
20. Candida norvegensis fungemia in a liver transplant recipient.
Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A
Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]